VeriMom¿Es symphytum officinale root extract seguro durante el embarazo?
Symphytum officinale (comfrey) root/leaf extracts contain pyrrolizidine alkaloids (PAs) that are hepatotoxic, genotoxic and associated with carcinogenicity and reported fetal/veno‑occlusive effects; regulatory bodies caution against internal use in pregnancy and some authorities advise avoiding topical use in pregnancy because of PA-related risks (EMA monograph; PubMed reviews). Skin‑permeation studies show PAs are poorly absorbed through intact human skin but measurable, so topical exposure is low but not zero. (Sources: EMA herbal monograph; PubMed review of Symphytum species; human skin permeation study).
Pregnancy-safe products containing symphytum officinale root extract
Alternativas seguras a symphytum officinale root extract en el embarazo | VeriMom
Related ingredients
Frequently asked questions
- ¿Es symphytum officinale root extract seguro durante el embarazo?
- Symphytum officinale (comfrey) root/leaf extracts contain pyrrolizidine alkaloids (PAs) that are hepatotoxic, genotoxic and associated with carcinogenicity and reported fetal/veno‑occlusive effects; regulatory bodies caution against internal use in pregnancy and some authorities advise avoiding topical use in pregnancy because of PA-related risks (EMA monograph; PubMed reviews). Skin‑permeation studies show PAs are poorly absorbed through intact human skin but measurable, so topical exposure is low but not zero. (Sources: EMA herbal monograph; PubMed review of Symphytum species; human skin permeation study).
- ¿Es symphytum officinale root extract seguro durante la lactancia?
- Because PAs in comfrey are hepatotoxic and have been implicated in infant toxicity and are discouraged during lactation, breastfeeding is cautioned; dermal/topical exposure can result in measurable but low absorption and there are case reports and regulatory warnings advising avoidance with nursing due to risk to the suckling infant. Mechanism is PA metabolic activation with genotoxic/hepatotoxic effects. (Sources: EMA monograph; regulatory advisories; PubMed reviews).
- ¿Es symphytum officinale root extract seguro para la piel del bebé?
- Infants (0–3 yr) have higher skin permeability and higher surface‑area‑to‑weight, so exposure score is increased. Given comfrey’s content of pyrrolizidine alkaloids (hepatotoxic/genotoxic), and documented infant/fetal cases and regulatory cautions (including advice to avoid use on nursing mothers and infants), residual PA on skin or transfer via breast/chest application could pose risk; although dermal PA absorption was shown to be low in one ex vivo study, infant susceptibility and cases justify conservative approach. (Sources: PubMed review; skin permeation study; regulatory guidance).
- ¿Cómo puntúa VeriMom a symphytum officinale root extract?
- VeriMom puntúa symphytum officinale root extract en 40/100 (riesgo medio) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a symphytum officinale root extract en el embarazo?
- Consulta nuestra lista de alternativas seguras a symphytum officinale root extract según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.